Table 1. Patient characteristics for primary AML patient samples.

Patient	Gender	Age (years)	Disease Status	FAB subtype	Cytogenetics	Blast purity (%)	Gene mutation
AML#110	Female	66	Relapsed	M4	45, XX, −7	48.0
AML#111	Male	58	Newly diagnosed	M2	46, XY	63.5	CEBPα double mutation, DNMT3A mutation, GATA2 mutation
AML#112	Male	46	Newly diagnosed	M1	46, XY	92.0	CEBPα double mutation
AML#113	Female	10	Newly diagnosed	M5	46, XX	97.0

Abbreviation: AML, acute myeloid leukemia.